CClinicalTrials.gg
CompletedNCT06265571Updated Feb 20, 2024

Postoperative Pain in Shoulder Surgery

An observational study in Pain, Postoperative, sponsored by Eskisehir Osmangazi University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by Eskisehir Osmangazi University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
40
Ages
18 Years to 75 Years
Sex
All
01

Study summary

After the approval of the ethics committee, the files of the patients who underwent arthroscopic shoulder surgery between 01.01.2019 and 01.03.2020 were evaluated retrospectively.

Data were recorded including age, gender, duration of anesthesia, duration of surgery, postoperative analgesia consumption, complications such as respiratory distress due to hemidiaphragmatic paralysis and complications such as hematoma and nerve damage due to block intervention.

Read the detailed description

Patients who underwent arthroscopic shoulder surgery and underwent USG-guided interscalene block and concomitant suprascapular block were included in the study. We tried to determine whether there is a difference between different dose regimens in order to determine the effective analgesic dose and minimize the side effects of dose-dependent interscalene block applications.

02

Conditions studied

  • Pain, Postoperative
03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

This study's enrollment of 40 is below the median of 82 across 130 observational studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Eskisehir Osmangazi University is the lead sponsor of 149 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

>18 years old patients undergoing arthroscopic shoulder surgery by the same surgeon.

Inclusion criteria

arthroscopic shoulder surgery full data form

Exclusion criteria

Exclusion Criteria:

chronic obstructive lung disease chronic opoid consumption missing data from the postoperative pain form

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
40 participants (actual)
Patient registry
No

Groups and cohorts

  • GROUP I

    Interscalene block (group I)15 ml of 0.5% bupivacaine was applied with a single injection to 12 of 18 patients,

    Other: perineural injection

  • GROUP II

    7.5 ml of interscalene and 7.5 ml of suprascapular block (GROUP II) were applied to 6 patients with posterior approach.

    Other: perineural injection

Interventions

  • Otherperineural injection

    perineural injection of local anesthestetic for postoperative pain management

06

What researchers measure

Primary outcomes

  1. rescue analgesia

    postoperative pain score (VAS) \> 4 required to rescue analgesia

    Time frame: between 01.01.2019 and 01.03.2020

  2. difference between the analgesic methods

    Time frame: between 01.01.2019 and 01.03.2020

07

Study locations

1 site
  • Ferda YAMAN
    Eskişehir, Odunpazarı 26040, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided — reterospectively completed

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06265571
Lead sponsor
Eskisehir Osmangazi University
Responsible party
Ferda YAMAN (Principal Investigator, Eskisehir Osmangazi University) — Principal investigator
First posted
Feb 20, 2024
Start date
Nov 15, 2020
Primary completion
Jun 15, 2021
Completion
Jul 15, 2021
Last update
Feb 20, 2024

Study contacts

Ferda YAMAN, Assoc prof
study director · University of Eskişehir Osmangazi

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion